CIK: 0002013341
申報總市值
US$4.6億
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CGON | Cg Oncology INC | 股票-其他 | 27.88% | +4.79% | — | |
| 2 | RAPT | Rapt Therapeutics INC | 股票-其他 | 16.00% | -16.00% | EXIT | |
| 3 | ALMS | Alumis INC | 股票-其他 | 12.53% | +7.80% | — | |
| 4 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 10.31% | +1.46% | +3.81% | |
| 5 | VSTM | Verastem INC | 股票-其他 | 7.32% | -3.70% | +19.88% | |
| 6 | DNLI | Denali Therapeutics INC | 股票-其他 | 4.99% | +0.06% | — | |
| 7 | NTRA | Natera INC | 股票-醫療保健 | 4.66% | -4.66% | EXIT | |
| 8 | AGIO | Agios Pharmaceuticals INC | 股票-其他 | 4.36% | -0.50% | — | |
| 9 | KYMR | Kymera Therapeutics INC | 股票-其他 | 3.44% | -0.79% | — | |
| 10 | ATAI | AtaiBeckley Inc. | 股票-其他 | 3.40% | -3.40% | EXIT | |
| 11 | CRVS | Corvus Pharmaceuticals INC | 股票-其他 | 3.21% | +2.61% | -20.22% | |
| 12 | HNGE | Hinge Health Inc-a | 股票-其他 | 1.90% | -0.05% | — |
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | ALMS | Alumis INC | +6% | — | 不變 |
| 2 | RAPT | Rapt Therapeutics INC | +0.4% | — | 不變 |
| 3 | KYMR | Kymera Therapeutics INC | +0.2% | — | 不變 |
| 4 | DNLI | Denali Therapeutics INC | -0.6% | — | 不變 |
| 5 | HNGE | Hinge Health Inc-a | -0.7% | — | 不變 |
| 6 | VSTM | Verastem INC | -1.6% | +19.88% | 加碼 |
| 7 | CRVS | Corvus Pharmaceuticals INC | -1.7% | -20.22% | 減碼 |
| 8 | 260 | Centessa Pharmaceuticals-adr | -2% | +3.81% | 加碼 |
| 9 | CGON | Cg Oncology INC | -6.7% | — | 不變 |
| 10 | NTRA | Natera INC | — | NEW | 新建倉 |
| 11 | AGIO | Agios Pharmaceuticals INC | — | NEW | 新建倉 |
| 12 | AKRO | Akero Therapeutics INC | — | EXIT | 清倉 |
| 13 | ATAI | AtaiBeckley Inc. | — | NEW | 新建倉 |
| 14 | RNAGBP | Avidity Biosciences INC | — | EXIT | 清倉 |
| 15 | ✓ | Casi Pharmaceuticals INC | — | EXIT | 清倉 |